Other prostate cell surface antigens, such as prostate stem cell antigen (PSCA) and six-transmembrane epithelial antigen of the prostate 1 (STEAP1), also exhibit nonspecific expression profiles, potentially leading to similar on-target, off-tumor effects (11–13). Here, STEAP1 is linked to neoplasm.